This inventor holds 14 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Astellas Pharma Gmbh, Saturn Licensing LLC, Hitachi, Ltd.. Active years: 1990-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa, JP (2018 - 2023)
- Tokyo, JP (1990 - 2024)
Company Filing History:
5 out of 424 
4 out of 719 
1 out of 42,740 
Years Active: 1990-2025
Title: The Innovative Journey of Soichiro Nakamura
Introduction
Soichiro Nakamura is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the pharmaceutical field. With a remarkable portfolio of 10 patents, his work primarily focuses on developing innovative pharmaceutical compositions aimed at enhancing drug release mechanisms and therapeutic efficacy.
Latest Patents
Nakamura's most recent patents highlight his expertise in modified release pharmaceutical compositions. One of the notable inventions involves a composition comprising (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, aimed at achieving a sustained release with a maximum blood drug concentration (Cmax) of 400 ng/ml or less when taken in a fasted state. Additionally, another patent reveals a similar pharmaceutical composition that includes essential additives, ensuring efficient water penetration into the composition, thus optimizing drug delivery.
Career Highlights
Throughout his career, Soichiro Nakamura has made substantial strides in pharmaceutical research and development. He has worked with esteemed organizations such as Astellas Pharma GmbH and Hitachi, Ltd., where he has played crucial roles in various innovative projects. His dedication to advancing pharmaceutical science has earned him recognition in the industry.
Collaborations
Nakamura's journey has not been solitary. He has collaborated with notable individuals in the field, including his coworkers Yuuki Takaishi and Yutaka Takahashi. These collaborations have fostered the exchange of ideas and propelled the advancement of their shared research interests.
Conclusion
Soichiro Nakamura's contributions to pharmaceutical innovation are noteworthy, showcasing his commitment to developing effective therapeutic solutions. With a solid foundation of patents and collaborations, he continues to influence the pharmaceutical landscape, paving the way for future advancements in drug formulation and delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile